Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) Applied to Platinum-Resistant Recurrence of Ovarian Tumor: A Single-Institution Experience (ID: PARROT Trial).

Giuseppe VizzielliMaria Teresa GiudiceFederica NardelliBarbara CostantiniVanda SalutariFrediano Socrate InzaniGian Franco ZannoniVito ChianteraAndrea Di GiorgioFabio PacelliAnna FagottiGiovanni Scambia

Published in: Annals of surgical oncology (2023)

PIPAC seems a feasible approach for the treatment of this subset of patients, without any impact on their quality of life. Since this study had a small sample size and a single-center design, future research is mandatory, such as its application in addition to systemic chemotherapy.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
locally advanced
chronic kidney disease
clinical trial
prognostic factors
peritoneal dialysis
study protocol
patient reported outcomes
squamous cell carcinoma
phase ii
rectal cancer